| Literature DB >> 33524672 |
Philippa Harding1, Dulce Lima Cunha1, Cécile Méjécase2, Jonathan Eintracht1, Lyes Toualbi2, Hajrah Sarkar2, Mariya Moosajee3.
Abstract
A human induced pluripotent stem cell (hiPSC) line (UCLi013-A) was generated from fibroblast cells of a 34-year-old donor with multiple ocular conditions including severe microphthalmia and aniridia. The patient had a heterozygous missense mutation in PAX6 c.372C>A, p.(Asn124Lys), validated in the fibroblasts through Sanger sequencing. Fibroblasts derived from a skin biopsy were reprogrammed using integration free episomal reprogramming. The established iPSC line was found to express pluripotency markers, exhibit differentiation potential in vitro and display a normal karyotype. This cell line will act as a tool for disease modelling of microphthalmia and aniridia, identification of therapeutic targets and drug screening.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33524672 PMCID: PMC7957338 DOI: 10.1016/j.scr.2021.102184
Source DB: PubMed Journal: Stem Cell Res ISSN: 1873-5061 Impact factor: 2.020